Navigation Links
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
Date:10/26/2009

Synageva BioPharma

Alternative Modes of Administration

Altus Pharmaceuticals

Baxter BioPharma Solutions

Chapter 3

MARKETED AND EMERGING MONOCLONAL

ANTIBODIES: PRESENT AND FUTURE

THERAPEUTICS

3.1. Approved Therapeutic Monoclonal Antibodies

Profiles of Therapeutic Monoclonal Antibodies Approved for

Marketing

Orthoclone OKT3 (Muromonab-CD3) (1986)

ReoPro (Abciximab) (1994)

Rituxan (Rituximab) (1997)

Zenapax (Daclizumab) (1997)

Simulect (Basiliximab) (1998)

Synagis (Palivizumab) (1998)

Remicade (Infliximab) (1998)

Herceptin (Trastuzumab) (1998)

Mylotarg (Gemtuzumab Ozogamicin) (2000)

Campath (Alemtuzumab) (2001)

Zevalin (Ibritumomab Tiuxetan) (2002)

Humira (Adalimumab) (2002)

Xolair (Omalizumab) (2003)

Bexxar (Tositumomab) (2003)

Raptiva (Efalizumab) (2003)

Erbitux (Cetuximab) (2004)

Avastin (Bevacizumab) (2004)

Tysabri (Natalizumab) (2006)

Lucentis (Ranibizumab) (2006)

Vectibix (Panitumumab) (2006)

Soliris (Eculizumab) (2007)

Cimzia (Certolizumab Pegol) (2008)

Ilaris (Canakinumab) (2009)

3.2. Monoclonal Antibodies in Development for Cancer

Unconjugated Monoclonal Antibodies for Cancer

Biogen Idec

Genentech

Human Genome Sciences

Immunomedics

ImClone Systems (Eli Lilly)

Morphotek (Eisai Corp. of North America)

Antisoma

Micromet

AVEO Pharmaceuticals

Northwest Biotherapeutics

Anti-idiotype Monoclonal Antibodies for Cancer

Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment

Menarini Group

Conjugated Mono
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
2. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
3. Reportlinker Adds Proteomics: Technologies and Global Markets Report
4. Reportlinker Adds Nanomedicine Report
5. Reportlinker Adds Small Molecule Kinase Inhibitors Report
6. Reportlinker Adds Nanoporous Materials Report
7. Reportlinker Adds Membrane Bioreactors Report
8. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
9. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
10. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
11. Reportlinker Adds Stem Cell Therapeutics Markets Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014  Next month, executives from clinical trial marketing firm ... beginning with Patient-Centered Clinical Trials 2014 , to be ... , September 4-5. Patient recruitment experts Bonnie A. ... will share insights on the benefits of employing an ... – from media to mobile apps – can be used ...
(Date:8/28/2014)... 2014  Armetheon, Inc. ( www.armetheon.com ), a ... late-stage cardiovascular drug candidates, today announced that it ... of financing. The Series A round was co-led ... participation from investors that included Atheneos Capital and ... Larry Hsu , the founder of Impax Laboratories. ...
(Date:8/28/2014)... A new market research report detailing ... from Strategic Consulting, Inc., the leading information resource ... Review, Fourth Edition: Global Review of Microbiology Testing ... compares microbiology test volumes, market values and methods ... and forecasts future volumes and market values through ...
(Date:8/28/2014)... Diego, CA (PRWEB) August 28, 2014 ... Pipette.com is offering a promotion for Eppendorf ... Pipette.com customers to purchase the highest quality tubes ... Tubes are ideal for customers doing chemical, medical, ... lab technicians who are not regularly able to ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3
... , INDIANAPOLIS, Dec. 16 /PRNewswire/ ... Indiana,s life sciences industry and an active venture capital market, ... Retirement Fund, Indiana University, Purdue University, the University of Notre ... the establishment of the INext Fund, a $58 million venture ...
... , , Toronto biotechnology company,s revenues increase ... flow in fiscal 2010 , TORONTO, Dec. 16 /PRNewswire-FirstCall/ ... on virology and biological technologies, today reported financial results ... year ended September 30, 2009, Microbix reported revenues of ...
... , Trial conducted pursuant to Special Protocol Assessment with ... 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ... focused on oncology and endocrine therapy, today announced the ... KERX), of a Phase 3 registration clinical trial for ...
Cached Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5
(Date:8/29/2014)... rise of the Tibetan plateau -- the largest topographic ... for both its profound effect on climate and its ... GSA Bulletin , Katharine Huntington and colleagues employ ... using modern and fossil snail shells to investigate the ... , Views range widely on the timing of ...
(Date:8/28/2014)... bacterial culprits that may drive inflammatory bowel diseases (IBD) ... own intestinal immune responses as a guide. , The ... Cell . , Trillions of bacteria exist within the ... the development and progression of IBD. Yet it,s thought ... a person,s susceptibility to IBD and its potential severity. ...
(Date:8/28/2014)... your neighbors than traditional cigarettes, but still release ... study from USC. , Scientists studying secondhand smoke ... exposure to harmful particles, with close-to-zero exposure to ... harmful metals in second-hand e-cigarette smoke were found ... contains high levels of polycyclic aromatic hydrocarbons ...
Breaking Biology News(10 mins):Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7Yale study identifies possible bacterial drivers of IBD 2Second-hand e-cig smoke compared to regular cigarette smoke 2
... the Biotechnology and Biological Sciences Research Council (BBSRC) have ... genetics, boosting our ability to produce disease- and pest-resistant ... evening (28 July) in the journal Science . ... Beynon at the University of Warwick, has used a ...
... Rochelle, NY, July 29, 2011Intravenous delivery of cold fluids ... and improve neurologic outcomes may not be as effective ... a study reported in Therapeutic Hypothermia and Temperature ... Liebert, Inc. The article is available free online at ...
... grasses, are likely to be pushed aside even more as ... University of California, Berkeley. In the study, which has ... Biology and is now available online, UC Berkeley biologists ... exotic grasses in the state and estimated how climate change ...
Cached Biology News:Plant immunity discovery boosts chances of disease-resistant crops 2Warming climate could give exotic grasses edge over natives 2Warming climate could give exotic grasses edge over natives 3
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... polyclonal to Uridine Phosphorylase 1 ( Abpromise ... Antigen: Synthetic peptide: MAATGANAEK AESHNDCPVR ... GTDRYAMYK, corresponding to amino acids 1-99 of ... Entrez Gene ID: 7378 ...
Request Info...
Lingo-1 (K-13)...
Biology Products: